research Management of severe childhood hypertension with minoxidil: A controlled clinical study
Minoxidil helps lower blood pressure in kids with severe hypertension, but may cause temporary excessive hair growth.
Search
forResearch
5 / 1000+ results research A call for clinical practice guidelines for the treatment of hypertension with East Asian medicine
research Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
Low-dose oral minoxidil can cause dizziness in women without lowering blood pressure, so careful monitoring is needed.
research Clinical Use of a Protein-Sparing Modified Fast
This article reviews the challenges of fasting and dietary regimens in producing sustained weight loss and reports no new research findings or results.
research Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women
This study found that women with polycystic ovary syndrome in the UK show significant differences in phenotypic and metabolic characteristics based on ethnicity, age, and obesity, influencing management strategies.
Community Join
5 / 1000+ resultscommunity 6 months before and after pics: VDPHL01 (oral minoxidil)
A user shared their positive experience with a clinical trial for a new oral medication, VDPHL01, which is a reformulated version of oral minoxidil taken at a high dose of 17mg daily, showing significant hair regrowth after six months. The user noted that this formulation is believed to be more effective and time-released, with fewer side effects compared to regular oral minoxidil.
community Low-Dose Oral Minoxidil Does Not Significantly Affect BP
Low-dose oral minoxidil is used for hair loss and does not significantly affect blood pressure but may increase heart rate and cause hypotensive symptoms. Some users experience side effects like palpitations and shortness of breath, while others find it effective; topical minoxidil with tretinoin is also considered.
community Exceedingly slow progress, or just short hair?
The user started using 0.5mg Dutasteride, switched to 10mg oral Minoxidil, and began micro-needling in February 2026, noticing slow but steady hair growth. Other users suggest using lower doses of Minoxidil and commend the visible progress.
community He used Dutasteride for 20 YEARS: TL;DR Slight gains and largely stable for 20 years.
John has experienced slight hair gains and stability over 20 years using Dutasteride, which is more effective than Finasteride in reducing scalp DHT and maintaining hair. Dutasteride at 0.5mg daily has a similar side effect profile to Finasteride, but at higher doses, it may increase the risk of sexual side effects.
community Oral Minoxidil: Dosing, Timing, PE Risk, and Why Your Weight Matters (with actual data)
Oral minoxidil dosing should be based on body weight to minimize side effects, with higher doses increasing risks like pericardial effusion. Combining oral minoxidil with topical treatments and finasteride can improve hair growth, but regular heart health monitoring is essential.
Learn
7 / 801 results- Are there clinical studies showing that KY19382 can regrow hair in androgenic alopecia? No clinical studies have proven KY19382 regrows hair in androgenic alopecia.
- What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth? No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.
- Are there any clinical studies supporting follistatin as a hair loss treatment? There is no controlled human trial showing follistatin treats hair loss; the published work is mouse and laboratory biology on the activin/follistatin signalling system, plus one small 2011 phase 1 injection study of a combination product, so follistatin remains experimental and unapproved.
- What types of hair loss conditions are most commonly associated with tofacitinib use in clinical settings? Published studies link tofacitinib mainly to alopecia areata and its severe variants — as an off-label drug being studied for them, not as a cause of hair loss. The evidence is mostly small, open-label or retrospective, and relapse after stopping is commonly reported.
- When will GT20029 be commercially available, and are there any clinical trials on its use? GT20029 is not approved or commercially available anywhere and remains investigational. A published 12-week Phase II study in 180 Chinese men reports hair-count gains over placebo, but no long-term or Phase III data exists, so any launch is years away at best.
learn Latanoprost
glaucoma medication with hair follicle stimulant effects
learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
learn KY19382
learn SCUBE3
learn Follistatin
learn Tofacitinib
learn GT20029
Clinics
6 / 500 results- 29
TrichologyHair TransplantCLINICAL HAIR&HEALTHOstrava · CZ - 33
Hair TransplantHair Loss TreatmentsClinical BédardMontréal, QC · CA - 11
Hair Loss TreatmentsClinical Francisco DuarteBelo Horizonte, MG · BR - 35
Hair Loss TreatmentsClinical Hair & beautyCórdoba, CB · AR - 12Hair Loss TreatmentsClinical Aesthetic SolvayLiège · BE
- 25Hair TransplantClinical Aesthetics of TulsaTulsa, OK · US
Experts
— no results